|
Mean levels of log-transformed measures during 28 days of follow-up |
||||
| Day |
N |
log(CRP) mg/L |
log (SAA) mg/L |
log (fibrinogen) mg/dL |
|
|
||||
| 1 |
16 |
0.72 ± 0.46 |
0.77 ± 0.51 |
2.64 ± 0.09 |
| 2 |
15 |
0.91 ± 0.53 |
0.97 ± 0.67 |
2.65 ± 0.11 |
| 3 |
20 |
0.99 ± 0.51 |
1.05 ± 0.71 |
2.70 ± 0.06 |
| 7 |
20 |
0.87 ± 0.56 |
0.93 ± 0.65 |
2.69 ± 0.08 |
| 14 |
19 |
0.90 ± 0.60 |
0.88 ± 0.60 |
2.60 ± 0.37 |
| 21 |
18 |
0.76 ± 0.61 |
0.85 ± 0.65 |
2.66 ± 0.12 |
| 28 |
17 |
0.91 ± 0.58 |
0.93 ± 0.64 |
2.66 ± 0.09 |
| P* |
0.7005 |
0.4764 |
0.6382 |
|
|
* p for trend over time using random effect models. | ||||
Elkind et al. BMC Neurology 2006 6:37 doi:10.1186/1471-2377-6-37 |
||||